Last reviewed · How we verify
Mepivacaine 2% with epinephrine 1:100,000
Mepivacaine 2% with epinephrine 1:100,000 is a Local anesthetic Small molecule drug developed by Qassim Health Cluster. It is currently in Phase 3 development for Local anesthesia for surgical procedures, dental procedures, and other painful conditions. Also known as: medicaine 2%.
Mepivacaine is a local anesthetic that blocks sodium channels to prevent nerve impulses, while epinephrine constricts blood vessels to prolong the anesthetic effect.
Mepivacaine is a local anesthetic that blocks sodium channels to prevent nerve impulses, while epinephrine constricts blood vessels to prolong the anesthetic effect. Used for Local anesthesia for surgical procedures, dental procedures, and other painful conditions.
At a glance
| Generic name | Mepivacaine 2% with epinephrine 1:100,000 |
|---|---|
| Also known as | medicaine 2% |
| Sponsor | Qassim Health Cluster |
| Drug class | Local anesthetic |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Anesthesiology |
| Phase | Phase 3 |
Mechanism of action
Mepivacaine works by inhibiting the influx of sodium ions into nerve cells, which prevents the initiation and transmission of nerve impulses. This results in a temporary loss of sensation in the affected area. Epinephrine, added to the solution, causes vasoconstriction, which reduces bleeding and prolongs the duration of the anesthetic effect.
Approved indications
- Local anesthesia for surgical procedures, dental procedures, and other painful conditions
Common side effects
- Numbness or tingling
- Headache
- Dizziness
- Nausea
- Vasodilation
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mepivacaine 2% with epinephrine 1:100,000 CI brief — competitive landscape report
- Mepivacaine 2% with epinephrine 1:100,000 updates RSS · CI watch RSS
- Qassim Health Cluster portfolio CI
Frequently asked questions about Mepivacaine 2% with epinephrine 1:100,000
What is Mepivacaine 2% with epinephrine 1:100,000?
How does Mepivacaine 2% with epinephrine 1:100,000 work?
What is Mepivacaine 2% with epinephrine 1:100,000 used for?
Who makes Mepivacaine 2% with epinephrine 1:100,000?
Is Mepivacaine 2% with epinephrine 1:100,000 also known as anything else?
What drug class is Mepivacaine 2% with epinephrine 1:100,000 in?
What development phase is Mepivacaine 2% with epinephrine 1:100,000 in?
What are the side effects of Mepivacaine 2% with epinephrine 1:100,000?
What does Mepivacaine 2% with epinephrine 1:100,000 target?
Related
- Drug class: All Local anesthetic drugs
- Target: All drugs targeting Voltage-gated sodium channels
- Manufacturer: Qassim Health Cluster — full pipeline
- Therapeutic area: All drugs in Anesthesiology
- Indication: Drugs for Local anesthesia for surgical procedures, dental procedures, and other painful conditions
- Also known as: medicaine 2%
- Compare: Mepivacaine 2% with epinephrine 1:100,000 vs similar drugs
- Pricing: Mepivacaine 2% with epinephrine 1:100,000 cost, discount & access